OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Improving these processes involves modifying various variables, including cell line engineering, media ingredients, and bioreactor environments. A key goal is to maximize antibody titer while reducing production expense